Clinical Trial Update: A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD [Phase 1]

View source ↗

Summary

Phase 1 repeat ascending dose trial to evaluate the safety and preliminary activity of R-3750 in adults with mild-to-moderate COPD, including those with COPD ex…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Exacerbation of Chronic Obstructive Pulmonary Disease

Drugs mentioned

• R-3750

Snippet

Sponsor: Rise Therapeutics LLC | Conditions: COPD (Chronic Obstructive Pulmonary Disease), COPD Exacerbation | Phase 1 | Status: NOT_YET_RECRUITING